Skip to main navigation
Skip to search
Skip to main content
University of Dundee Discovery Portal Home
Search content at University of Dundee Discovery Portal
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Biological response modifiers in cancer therapy
Shalini Gupta
, Avinash K. Kanodia
Undergraduate Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biological response modifiers in cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Cancer Therapy
100%
Biological Response Modifiers
100%
Anticancer Vaccines
40%
Tumor Necrosis Factor-α
40%
Monoclonal Antibody
40%
Interferon-α (IFN-α)
40%
Interleukin
40%
Immunostimulation
40%
Cancer Cells
20%
Tumor Angiogenesis
20%
Recent Advances
20%
Bleeding
20%
Chemotherapy
20%
Growth Factors
20%
Tumor Cells
20%
Radiotherapy
20%
Breast Cancer Treatment
20%
Thalidomide
20%
Heat Shock Proteins
20%
Carbohydrates
20%
Bone Marrow
20%
Inhibit Tumor
20%
Vaccination
20%
CSF-1
20%
Tumor-specific
20%
Host Immune Response
20%
Trastuzumab
20%
Malignant Melanoma
20%
Interleukin-2
20%
Leukemia
20%
Metastatic Renal Cell Carcinoma (mRCC)
20%
Antigen Delivery
20%
Kaposi Sarcoma
20%
Tumor Proliferation
20%
Non-Hodgkin Lymphoma
20%
Delivery Vectors
20%
Scientific Use
20%
Rituximab
20%
Recombinant Bacteria
20%
Optimum Choice
20%
Administration Regimen
20%
Tumor Immunology
20%
Recombinant Virus
20%
Antiangiogenic Properties
20%
DNA Bases
20%
DNA Coding
20%
Medicine and Dentistry
Cancer Therapy
100%
Biological Response Modifier
100%
Antigen
60%
Malignant Neoplasm
40%
Cancer
40%
Monoclonal Antibody
40%
Interferon
40%
Immunostimulation
40%
Cancer Cell
20%
Breast Cancer
20%
Angiogenesis
20%
Tumor Progression
20%
Tumor Cell
20%
Growth Factor
20%
Infection
20%
Tumor Necrosis Factor
20%
Bleeding
20%
Cytokine
20%
Tumor Necrosis
20%
Heat Shock Protein
20%
Non-Hodgkin Lymphoma
20%
Trastuzumab
20%
Leukemia
20%
Kidney Metastasis
20%
Kaposi Sarcoma
20%
Specific Tumor
20%
Thalidomide
20%
Carbohydrates
20%
Colony Stimulating Factor
20%
Antiangiogenic
20%
Rituximab
20%
Interleukin 2
20%
Interleukin Derivative
20%
Tumor Immunology
20%
Melanoma
20%
Radiation Therapy
20%
Virus
20%
Immune System
20%
Chemotherapy
20%
Bacterium
20%
Peptide
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biological Response Modifier
100%
Antigen
60%
Monoclonal Antibody
40%
Interferon
40%
Cytokine
20%
Breast Cancer
20%
Tumor Growth
20%
Antiangiogenic
20%
Growth Factor
20%
Thalidomide
20%
Tumor Necrosis
20%
Tumor Necrosis Factor
20%
Chemotherapy Regimens
20%
Infection
20%
Bleeding
20%
Heat Shock Protein
20%
Leukemia
20%
Nonhodgkin Lymphoma
20%
Carbohydrates
20%
Melanoma
20%
Trastuzumab
20%
Kidney Metastasis
20%
Kaposi Sarcoma
20%
Colony Stimulating Factor
20%
Rituximab
20%
Interleukin 2
20%
Interleukin Derivative
20%
Vaccination
20%
Virus
20%
Peptide
20%
Bacterium
20%